Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production

NCT03141827 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03141827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03141827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production
Lead sponsor
University Health Network, Toronto
Phase
Phase 2/3
Overall status
Completed
Start date
April 14, 2016
Completion date
April 26, 2017
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia